Finance Watch: Two Biopharma IPOs Bring US Total To 17
Dianthus Raises $72m As It Closes Reverse Merger
Public Company Edition: Neumora grossed $250m and RayzeBio raised $311m in the first initial public offerings since early August. Also, ImmunityBio completes $470m in equity and debt financings, Bausch + Lomb sells $1.4bn worth of notes and Arbutus is among firms making cuts to conserve cash.
